Literature DB >> 18184253

The Shikani Optical Stylet: a useful adjunct to airway management in a neonate with popliteal pterygium syndrome.

Andrea H Jansen1, Graham Johnston.   

Abstract

The craniofacial abnormalities of popliteal pterygium syndrome present unique challenges to the pediatric anesthetist. Congenital fibrous bands between the maxilla and mandible limit mouth opening and the tongue may be fused to the palate. We describe the use of the Shikani Optical Stylet, a novel fiberoptic endoscope, in the airway management of a neonate with popliteal pterygium syndrome and syngnathia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184253     DOI: 10.1111/j.1460-9592.2007.02401.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  5 in total

1.  Congenital Maxillomandibular Syngnathia: Review of Literature and Proposed New Classification System.

Authors:  Vijay Kumar; Vidya Rattan; Sachin Rai
Journal:  J Maxillofac Oral Surg       Date:  2019-11-20

2.  Anaesthetic Challenges in a Paediatric Patient with Escobar Syndrome-Difficult Airway and Postoperative Pneumothorax.

Authors:  Waleed Bin Ghaffar; Irfan Ul Haq; Arham Shahid; Samina Ismail
Journal:  Turk J Anaesthesiol Reanim       Date:  2021-12

3.  Airway management in Escobar syndrome: A formidable challenge.

Authors:  Shaji Mathew; Souvik Chaudhuri; Hd Arun Kumar; Tim Thomas Joseph
Journal:  Indian J Anaesth       Date:  2013-11

4.  Successful airway management using a MultiViewScope handle with a stylet scope in a patient with Schwartz-Jampel syndrome.

Authors:  Keika Mukaihara; Kohei Godai; Tomotsugu Yamada; Maiko Hasegawa-Moriyama; Yuichi Kanmura
Journal:  JA Clin Rep       Date:  2016-11-14

5.  Application of second-generation Shikani optical stylet in critically ill patients undergoing cerebral aneurysm embolization.

Authors:  Xicheng Liu; Yaoxian Zhang; Zhanli Liu; Qiuli Zhang; Wenyan Wu; Zihao Zheng; Zhongjun Zhang
Journal:  J Int Med Res       Date:  2019-02-06       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.